p53 gene status and modulation of response to cisplatin chemotherapy in non-small cell lung cancer cells

被引：0
|
作者：
Barr, M. P. [1 ,2 ]
Batina, M. B. [1 ,2 ]
Cuffe, S. [1 ,2 ]
Finn, S. [1 ,2 ,3 ]
O'Byrne, K. J. [1 ,2 ,4 ]
机构：
[1] St James Hosp, Thorac Oncol Res Grp, Dublin, Ireland
[2] Univ Dublin Trinity Coll, Dublin 2, Ireland
[3] St James Hosp, Dept Histopathol, Dublin, Ireland
[4] Queensland Univ Technol, Canc & Ageing Res Program, Brisbane, Qld 4001, Australia
来源：
LUNG CANCER | 2014年 / 83卷
关键词：
D O I：
10.1016/S0169-5002(14)70003-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [41] Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer
    Gregorc, V
    Ludovini, V
    Pistola, L
    Darwish, S
    Floriani, I
    Bellezza, G
    Sidoni, A
    Cavaliere, A
    Scheibel, M
    De Angelis, V
    Bucciarelli, E
    Tonato, M
    LUNG CANCER, 2003, 39 (01) : 41 - 48
  • [42] Prognostic role of p53 in stage III non-small cell lung cancer
    Berghmans, T
    Mascaux, C
    Martin, B
    Ninane, V
    Sculier, JP
    ANTICANCER RESEARCH, 2005, 25 (3C) : 2385 - 2389
  • [43] Prognostic value of p53 abnormalities in non-small cell lung cancer (NSCLC)
    Niklinski, J
    Chyczewski, L
    Niklinska, W
    Laudanski, J
    Furman, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S248 - S248
  • [44] EXPRESSION OF FRAGILE HISTIDINE TRIAD AND P53 IN NON-SMALL CELL LUNG CANCER
    侯兴华
    张道荣
    Chinese Journal of Cancer Research, 2006, (02) : 121 - 126
  • [45] Growth inhibitory role of the p53 activator SCH 529074 in non-small cell lung cancer cells expressing mutant p53
    Nenkov, Miljana
    Ma, Yunxia
    Haase, Daniela
    Zhou, Zhongwei
    Li, Yong
    Petersen, Iver
    Lu, Guanghua
    Chen, Yuan
    ONCOLOGY REPORTS, 2020, 43 (06) : 2073 - 2082
  • [46] Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients
    Gessner, C
    Kuhn, H
    Toepfer, K
    Hammerschmidt, S
    Schauer, J
    Wirtz, H
    LUNG CANCER, 2004, 43 (02) : 215 - 222
  • [47] Types and localisation of p53 gene mutations -: A report on 332 non-small cell lung cancer patients
    Jassem, E
    Niklinski, J
    Rosell, R
    Niklinska, W
    Jakóbkiewicz, J
    Monzo, M
    Chyczewski, L
    Kobierska, G
    Skokowski, J
    Zylicz, M
    Jassem, J
    LUNG CANCER, 2001, 34 : S47 - S51
  • [48] PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 status
    Dabir, Snehal
    Kluge, Amy
    McColl, Karen
    Liu, Yu
    Lam, Minh
    Halmos, Balazs
    Wildey, Gary
    Dowlati, Afshin
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (05) : 1045 - 1054
  • [49] Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)
    Wang, GD
    Reed, E
    Li, QQ
    ONCOLOGY REPORTS, 2004, 12 (05) : 955 - 965
  • [50] Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma
    Tomizawa, Y
    Kohno, T
    Fujita, T
    Kiyama, M
    Saito, R
    Noguchi, M
    Matsuno, Y
    Hirohashi, S
    Yamaguchi, N
    Nakajima, T
    Yokota, J
    ONCOGENE, 1999, 18 (04) : 1007 - 1014
12345